Diffuse recurrent cutaneous melanoma of the scalp and neck successfully treated with volumetric modulated arc therapy and concurrent ipilimumab

Pract Radiat Oncol. 2018 May-Jun;8(3):174-178. doi: 10.1016/j.prro.2017.09.006. Epub 2017 Sep 19.

Authors

Ryan K Schmid¹, Amy Harker-Murray², Karen Niemczyk³, Jared R Robbins⁴

Affiliations

¹ Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
² Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
³ Froedtert Health, Kraemer Cancer Center, West Bend, Wisconsin.
⁴ Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: jrobbins@mcw.edu.

PMID: 29122555
DOI: 10.1016/j.prro.2017.09.006

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use*
Female
Humans
Ipilimumab / pharmacology
Ipilimumab / therapeutic use*
Melanoma / drug therapy*
Melanoma / pathology
Melanoma / radiotherapy*
Melanoma, Cutaneous Malignant
Neck / pathology*
Neoplasm Recurrence, Local
Radiotherapy, Intensity-Modulated / methods*
Scalp / pathology*
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Skin Neoplasms / radiotherapy*

Substances

Antineoplastic Agents, Immunological
Ipilimumab